TABLE 3.
Factors associated with successful ablation (central review residual disease information)
| Successful ablation (n = 80) | Unsuccessful ablation (n = 7) | p-Value | |
|---|---|---|---|
| MRI status | 0.37 | ||
| Residual enhancement | 20 (87.0) | 3 (13.0) | |
| No residual enhancement | 60 (93.8) | 4 (6.2) | |
| HR status | 0.99 | ||
| Negative | 4 (100.0) | 0 | |
| Positive | 76 (91.6) | 7 (8.4) | |
| Tumor grade | 0.38 | ||
| Low | 29 (96.7) | 1 (3.3) | |
| Intermediate | 31 (88.6) | 4 (11.4) | |
| High | 12 (85.7) | 2 (14.3) | |
| Tumor size, cm | 0.34 | ||
| <1.0 | 16 (100.0) | 0 | |
| ≥1.0 | 64 (90.1) | 7 (9.9) | |
| MRI status for tumor size <1.0 | |||
| Residual enhancement | 5 (100.0) | 0 | |
| No residual enhancement | 11 (100.0) | 0 | |
| MRI status for tumor size ≥1.0 | 0.36 | ||
| Residual enhancement | 15 (83.3) | 3 (16.7) | |
| No residual enhancement | 49 (92.4) | 4 (7.6) | |
|
| |||
| Successful ablation or MRI residual disease | Unsuccessful ablation and MRI no residual disease | ||
|
|
|||
| Tumor size, cm | 0.99 | ||
| <1.0 | 16 (100.0) | 0 | |
| ≥1.0 | 67 (94.4) | 4 (5.6) | |